SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-20-009232
Filing Date
2020-01-31
Accepted
2020-01-31 16:31:31
Documents
1
Period of Report
2020-03-02
Effectiveness Date
2020-01-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv537242-def14a.htm DEF 14A 107512
  Complete submission text file 0001104659-20-009232.txt   108599
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-13341 | Film No.: 20565490
SIC: 2836 Biological Products, (No Diagnostic Substances)